Real-Time Quaking-Induced Conversion Analysis for the Diagnosis of Sporadic Creutzfeldt-Jakob Disease in Korea

다국어 초록 (Multilingual Abstract)

Background and Purpose Te level of 14-3-3 protein in the cerebrospinal fuid (CSF) is increased in Creutzfeldt-Jakob disease (CJD) patients, which has led to it being used as a clinical biomarker for the ante-mortem diagnosis of human prion diseases. However, the specifcity of the 14-3-3 protein is less reliable for CJD diagnosis. Newly developed assays including real-time quaking-induced conversion (RT-QuIC) have made it possible to detect the PrPSc-like abnormal prion isoform with a high sensitivity in animal and human specimens that might contain a minute amount of PrPScdue to in vitro prion replication.
MethodszzTis study applied a highly sensitive RT-QuIC assay using recombinant human PrP to detect PrPScin the CSF of 81 patients with sporadic CJD (sCJD) in Korea.
ResultszzRT-QuIC analysis of the CSF samples based on the expression levels of 14-3-3 and total tau proteins revealed positivity in 62 of 81 sCJD patients (sensitivity of 76.5%) but no positive results in the 100 non-CJD patients.
Conclusions Te sensitivity of the RT-QuIC in this study was similar to that in some previous reports, and the specifcity of RT-QuIC was higher than that of 14-3-3 in CSF, suggesting that RT-QuIC analysis can complement the weakness of the specifcity of 14-3-3 for the diagnosis of sCJD. Tese results indicate that RT-QuIC might be very useful for the rapid and specifc diagnosis of sCJD and provide a practical novel method for the ante-mortem diagnosis of human prion diseases.

참고문헌 (Reference)

1 Atarashi R, "Ultrasensitive human prion detection in cerebrospinal fluid by realtime quaking-induced conversion" 17 : 175-178, 2011

2 Peden AH, "Sensitive and specific detection of sporadic Creutzfeldt-Jakob disease brain prion protein using real-time quaking-induced conversion" 93 (93): 438-449, 2012

3 Atarashi R, "Real-time quaking-induced conversion: a highly sensitive assay for prion detection" 5 : 150-153, 2011

4 Orrú CD, "Rapid and sensitive RT-QuIC detection of human Creutzfeldt-Jakob disease using cerebrospinal fluid" 6 (6): e02451-02414, 2015

5 Tschampa HJ, "Radiological assessment of Creutzfeldt-Jakob disease" 17 : 1200-1211, 2007

6 LeVine H 3rd, "Quantification of beta-sheet amyloid fibril structures with thioflavin T" 309 : 274-284, 1999

7 Aguzzi A, "Progress and problems in the biology, diagnostics, and therapeutics of prion diseases" 114 : 153-160, 2004

8 Jeong BH, "Polymorphisms of the prion protein gene (PRNP) in a Korean population" 49 : 319-324, 2004

9 Orrù CD, "New generation QuIC assays for prion seeding activity" 6 : 147-152, 2012

10 Shimada T, "Neuroprotective function of 14-3-3 proteins in neurodegeneration" 2013 : 564534-, 2013

11 양태일, "Familial Creutzfeldt-Jakob Disease with V180I Mutation" 대한의학회 25 (25): 1097-1100, 2010

12 Sano K, "Early detection of abnormal prion protein in genetic human prion diseases now possible using real-time QUIC assay" 8 : e54915-, 2013

13 Skillbäck T, "Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality Registry" 71 : 476-483, 2014

14 Kübler E, "Diagnosis of prion diseases" 66 : 267-279, 2003

15 Cramm M, "Characteristic CSF prion seeding efficiency in humans with prion diseases" 51 : 396-405, 2015

16 Stoeck K, "Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years" 135 (135): 3051-3061, 2012

17 Orrú CD, "A test for Creutzfeldt-Jakob disease using nasal brushings" 371 : 519-529, 2014